Abu Dhabi Biobank and BioTwin Announce Strategic Partnership to Expand Human Virtual Twin Technology in the UAE
San Diego, California, July 01, 2026 – Abu Dhabi Biobank, a strategic initiative between the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and global health leader M42, announced a strategic partnership with BioTwin to expand the deployment of their AI-based Virtual Human Twin technology focusing on early detection, prevention and precision health in Abu Dhabi.
Announced on the sidelines of BIO International Convention 2026 in San Diego, USA, this partnership combines BioTwin’s longitudinal biomarker platform and Virtual Human Twin technology with Abu Dhabi Biobank’s ability to connect biological data with genomic, clinical, and AI-driven insights to decode complex diseases, accelerate clinical research, and shift care from reactive to proactive. The collaboration aims to accelerate the translation of advanced health data into early signals, prevention strategies and more personalized care, with the first application focusing on multi-cancer screening.
Abu Dhabi has established itself as a leading hub for health innovation, advanced clinical infrastructure, biobanking, genomics, research and real-world implementation. Through this collaboration, BioTwin and Abu Dhabi Biobank aim to contribute to that ecosystem by advancing a scalable model for early detection and preventive precision health.
H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: “Abu Dhabi has successfully built a global living lab for intelligent life sciences. By connecting population-scale genomics, advanced longitudinal health data, and real-world evidence with agile regulation, we have created a single, future-ready ecosystem. This model creates the foundation for predictive, preventive and personalised future of health, resulting in earlier intervention at population scale that builds a healthier community. This partnership reflects Abu Dhabi’s competitive advantage, positioning the Emirate as a premier global hub to build, test and scale the next generation of life sciences innovation.”
Albarah El-Khani, Chief Operating Officer, Integrated Health Solutions, M42 said: “This collaboration is a powerful example of how advanced biobanking infrastructure can be directly connected to enable earlier detection, personalized prevention and therapeutic innovation. Abu Dhabi Biobank provides not only access to high-quality biological materials, but also to data, governance and translational pathways. We are committed to advancing precision medicine through world-class biobanking, data infrastructure and innovation. BioTwin supports this ambition with its cutting-edge tech platform to enable earlier detection, personalized prevention and future-ready healthcare models across the UAE.”
The partnership creates a foundation for future clinical, operational and commercial deployment opportunities in Abu Dhabi, starting with early detection and expanding toward broader applications in preventive health, health optimization and personalized care.
Louis-Philippe Noel, Founder and Chief Executive Officer of BioTwin said: “This partnership with the Abu Dhabi Biobank represents a major step in BioTwin’s mission to make early detection, prevention and personalized health optimization accessible through Human Virtual Twin technology. Abu Dhabi is building one of the most advanced precision health ecosystems in the world. Together with Abu Dhabi Biobank, we have the opportunity to expand a technology platform that can support earlier insight, longitudinal health monitoring and a more proactive model of care.”
BioTwin’s platform combines home-based dried blood spot collection, multi-biomarker analysis and AI-enabled Human Virtual Twin modeling to help generate longitudinal insights into individual health trajectories.
-Ends-
Notes to editors
About Abu Dhabi Biobank
Abu Dhabi Biobank is a strategic priority and a key pillar of health transformation, developed in partnership between the Department of Health – Abu Dhabi and M42. As a unique global biobanking hub, Abu Dhabi Biobank is a catalyst for scientific breakthroughs, expediting drug discovery and advancing life sciences research to deliver preventive, personalized and precise healthcare for all. Its offering spans the region’s largest hybrid cord blood bank, a pan human bank storing biological materials including tumours and tissues, and a national eye bank strengthening local transplantation capabilities. The initiative positions Abu Dhabi as a leading destination for biobanking excellence and precision healthcare, shaping the future of global health leveraging collaboration with key healthcare and life sciences partners.
About BioTwin
BioTwin is a health technology company developing a Human Virtual Twin platform for early detection, prevention and personalized health optimization. The company combines home-based dried blood spot collection, advanced biomarker analysis, longitudinal data and AI to create individualized virtual twins that support proactive health insights over time. BioTwin’s mission is to make precision health more accessible, scalable and actionable for individuals, clinicians and healthcare systems.
Media Contacts
Abu Dhabi Biobank
Anismita Ghosh
Manager, Marketing